CD38+ NK cells: novel players in immunoregulation - Takeaways - MDSpire

CD38+ NK cells: novel players in immunoregulation

  • By

  • Xiaotian Chang

  • Kehua Fang

  • May 29, 2026

  • 0 min

Share

  • 1

    CD38 is a transmembrane protein that degrades NAD+ and is expressed in various immune cells, including NK cells.

  • 2

    In rheumatoid arthritis, CD38+ NK cells produce high levels of IFN-γ and low levels of TGF-β, disrupting immune tolerance.

  • 3

    In colorectal cancer, CD38+ NK cells produce low levels of IFN-γ and high levels of TGF-β, promoting Treg differentiation.

  • 4

    CD38+ NK cells exhibit opposing regulatory effects on immune balance, influenced by their CD16 expression.

  • 5

    The expression of HSPA1B, a tumor suppressor, is decreased in CD38+ NK cells from colorectal cancer patients.

Original Source(s)

Related Content